Lower respiratory tract infections, urinary tract infections. 

Fluoroquinolones include the following : Ciprofloxacin, Norfloxacin, Lomefloxacin, Ofloxacin, Pefloxacin, Enoxacin

Refer Ciprofloxacin 

Approved by FDA on February 21,1992

Stevens Jhonsons syndrome.Acute renal failure. Generally well tolerated.

Commonly reported side effects are,nausea, abdominal pain or disconfort, and diarrhoea.

Less frequent effects are headache, dizziness, transcient insomnia,rash, pruritus, urticarai, photosensitivity. Slight and usually transient elevation of serum transaminase and blood urea nitrogen have been reported rarely. Leucopenia, thrombocytopenia.

Hypersens to the drug or other quinolone antibacterials. No documented controlled studies in pregnant and lactatingmothers. Safety and effectiveness of the drug in children under 18 years not established.

Special precautions:

Adjust dosage in impaired renal function.

Possibly photosentivity reaction.

Avoid exposure to excessive sunlight or artificial U.V light.

Discontinue treatment if sensitivity occurs. Epilepsy, Myasthenia gravis.

Approved by FDA on February 21,1992

Lower respiratory tract infections, urinary tract infections.

Dosage:

Daily dose 400mg, once daily for 10 to 14 days depnding on severity of infections.

Refer fluoroquinolones

Refer fluroquinolones

Food reduces the rate but not the extent of absorption.

Refer fluoroquinolones